Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06657430 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study on the Preference of Risperidone Dosage Forms

StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 24, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Trial Details
NCT Number NCT06657430
Lead Sponsor Shanghai Mental Health Center
Conditions
(from sponsor)		 Schizophrenia, Bipolar Affective Disorder, Autism Spectrum Disorder, Conduct Disorder, Mental Retardation
Related terms Autism Spectrum Disorder, Bipolar Disorder, Conduct Disorder, Intellectual Disability, Schizophrenia
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov